TFAP2A and breast carcinoma: The results showed that USP30-AS1, TFAP2A-AS1, MAPT-AS1, and LINC01087 expression were significantly increased and HOXB-AS1 expression was significantly decreased in breast cancer tissues compared with normal breast tissue (Figure 9A, P<0.001).